Close

Pre-Open Stock Movers 10/26: (WBX) (BKKT) (OCGN) Higher; (VTNR) (CLAR) (BYND) Lower (more...)

October 26, 2021 9:28 AM EDT

Pre-Open Stock Movers:

Wallbox N.V. (NYSE: WBX) 163% HIGHER; Uber (NYSE: UBER), a global mobility and delivery platform, and Wallbox N.V. (NYSE: WBX), a leading provider of electric vehicle (EV) charging and energy management solutions worldwide, today announced a strategic partnership to simplify the transition to EVs for Bay Area ride share drivers using Uber.

Bakkt Holdings, Inc. (NYSE: BKKT) 21.3% HIGHER; adds to Monday's 234% gain on deals with Mastercard and Fiserv.

Ocugen (NASDAQ: OCGN) 18.5% HIGHER; Climbs Pre-Open Amid Reports Covaxin May Get WHO EUA

Vertex Energy, Inc. (NASDAQ: VTNR) 15.6% LOWER; announced its intention to offer, subject to market conditions and other factors, $155 million aggregate principal amount at maturity of its convertible senior notes due 2027 (the "notes") in a private offering (the "offering") to persons reasonably believed to be qualified institutional buyers and/or to "accredited investors" in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities Act").

AnaptysBio, Inc. (Nasdaq: ANAB) 12.2% HIGHER; announced the signing of an agreement with Sagard Healthcare Royalty Partners to monetize a portion of AnaptysBios future JEMPERLI royalties and milestones. AnaptysBio intends to utilize the proceeds of the transaction towards funding of its wholly-owned preclinical and clinical-stage antibody programs.

Geron Corporation (Nasdaq: GERN) 8.2% HIGHER; announced that imetelstat, the Companys first in class telomerase inhibitor, has been granted an Innovation Passport, which is the first prescribed entry point to the Innovative Licensing and Access Pathway (ILAP) launched in the United Kingdom (UK) by the Medicines and Healthcare products Regulatory Agency (MHRA) in January 2021, post-Brexit. The objective of this new licensing and access pathway is to reduce the time to market for innovative medicines. Key benefits of being within ILAP include a 150-day accelerated assessment and rolling review of a Marketing Authorization Application (MAA), as well as opportunities for frequent interactions with the review staff at the MHRA and its partner agencies, including the National Institute for Health and Care Excellence (NICE), to discuss imetelstats development, regulatory plans and reimbursement plans.

DraftKings (NASDAQ: DKNG) 6.3% HIGHER; confirms that, following further analysis and discussions with the Entain board of directors, it will not make a firm offer for Entain.

Clarus Corporation (NASDAQ: CLAR) 5.8% LOWER; intends to offer, subject to market and other conditions, 2,750,000 shares of common stock registered under the Securities Act of 1933, as amended. The Company also expects to grant to the underwriters an option for 30 days to purchase up to an additional 412,500 shares of common stock.

Velo3D Inc. (NYSE: VLD) 4.6% HIGHER; Needham & Company initiates coverage with a Buy rating and a price target of $15.00.

UPS (NYSE: UPS) 4.3% HIGHER; reported Q3 EPS of $2.71, $0.17 better than the analyst estimate of $2.54. Revenue for the quarter came in at $23.2 billion versus the consensus estimate of $22.56 billion. For the full year in 2021, the company is raising its consolidated adjusted operating margin target to approximately 13.0% and expects adjusted return on invested capital to be around 29%. Capital expenditures are now planned to be approximately $4.2 billion and the company’s effective tax rate is expected to be about 22.5%.

Coty Inc. (NYSE: COTY) 3.6% HIGHER; Deutsche Bank upgraded from Hold to Buy with a price target of $11.00 (from $10.00).

    Universal Health (NYSE: UHS) 3% LOWER; reported Q3 EPS of $2.67, $0.07 worse than the analyst estimate of $2.74. Revenue for the quarter came in at $3.16 billion versus the consensus estimate of $3.1 billion.

    Beyond Meat Inc. (NASDAQ: BYND) 2.9% LOWER; Credit Suisse downgraded from Neutral to Underperform with a price target of $75.00 (from $123.00).

    Facebook (NASDAQ: FB) 2.3% HIGHER; reported Q3 EPS of $3.22, $0.03 better than the analyst estimate of $3.19. Revenue for the quarter came in at $29.01 billion versus the consensus estimate of $29.58 billion. Facebook sees Q4 revenue of $31.5 to $34 billion vs consensus of $34.89 billion.

    Upstart Holdings Inc (NASDAQ: UPST) 1.8% LOWER; Jefferies downgraded from Buy to Hold with a price target of $333.00 (from $160.00).



    Serious News for Serious Traders! Try StreetInsider.com Premium Free!

    You May Also Be Interested In





    Related Categories

    Special Reports

    Related Entities

    Credit Suisse, Deutsche Bank, Jefferies & Co, Needham & Company, Pre-Open Losers, Pre-Open Winners, Pre Market Movers